Already Autism Health Expands Rapidly with Three Major Acquisitions

Three Deals in One Week

CHARLOTTE, N.C. — The week of January 23, 2025, was a defining moment for Already Autism Health. On Thursday, January 23, the company announced that it had secured its first round of private equity investment from a group of three firms led by Triton Pacific Healthcare Partners, which became the majority shareholder. Star Mountain Capital and Ace & Company participated via debt and equity. Terms of the deal were not disclosed. Neither Derek Bullard’s Already Autism Health nor the companies it was about to acquire had been backed by investors before these respective deals.

The very next day, Friday, January 24, Already Autism Health announced the acquisition of Commonwealth ABA, a Florence, Kentucky–based provider founded in 2023 by Brett Blevins. Commonwealth had developed a reputation for delivering high-quality autism services to children and adolescents with autism spectrum disorder and had built 15 locations across Georgia, Kentucky, Indiana, and Virginia in under two years. The acquisition was the first tuck-in under the new PE sponsorship, and it immediately expanded Already Autism Health’s footprint into four new states.

Days later, on February 3, came the second acquisition: C.A.B.S. Autism & Behaviour Specialists, founded in 2008 by Amanda Parker, BCBA. C.A.B.S. had locations in Illinois and Georgia and had built a strong reputation for evidence-based behavioral therapy over nearly two decades. The acquisition added Illinois to Already Autism Health’s footprint and deepened the company’s presence in Georgia, where both Commonwealth and C.A.B.S. operated.

The speed of execution was notable even in a market accustomed to rapid PE-backed roll-ups. Behavioral Health Business described the three deals as part of a flurry of dealmaking activity in behavioral health, especially autism therapy, in early 2025. The deals were coordinated: Triton Pacific’s investment provided the capital, and the two acquisitions were already in the pipeline. The simultaneous announcement of the PE investment and the first acquisition signaled that Already Autism Health had been preparing for this moment for months, if not longer.

Rajat Bangar of Welham Advisory advised Already Autism Health on both transactions. Alex Veach and Ryan Lafferty of Agenda Health advised both sellers — an unusual arrangement in which the same advisory firm represented both acquisition targets, reflecting the coordinated nature of the deal process. DLA Piper, led by Sal Favuzza and Josh Kaye, represented Triton Pacific. Strauss Troy represented Commonwealth ABA.

The autism services space is undergoing rapid evolution but remains one of the most underserved sectors in all of healthcare. A leading platform like Already Autism Health stands to not only benefit from sector tailwinds but also play a key role in propelling the sector forward. — Joe Davis, Managing Partner, Triton Pacific Healthcare Partners

The Founder and the Platform

Derek Bullard co-founded Already Autism Health in 2019 with a mission to nurture the already remarkable abilities of persons with autism. The company’s name itself is a statement of clinical philosophy: the word already reflects a strengths-based approach that focuses on what children with autism can do rather than what they cannot. Bullard remains a significant stakeholder in the company alongside Triton Pacific’s majority position.

The company grew rapidly from its founding. By 2024, Already Autism Health had earned accreditation from the Behavioral Health Center of Excellence (BHCOE), a distinction that signals clinical quality and operational rigor to both families and investors. The company ranked No. 132 on the 2024 Inc. 5000 list of the fastest-growing private companies in America and was identified as the fourth-fastest growing behavioral health company in the country. That growth trajectory — from founding to Inc. 5000 recognition in five years — attracted the PE interest that culminated in the January 2025 deals.

Bullard described the Triton Pacific partnership as an opportunity to amplify the company’s mission while expanding its footprint, noting that their expertise and strategic vision align perfectly with our goal of providing high-quality, evidence-based autism services. The investment will go to expanding Already Autism Health’s geographic presence through new centers in new regions and adding testing and diagnostics in existing markets where those services are not presently offered. The addition of diagnostic evaluation services is strategically significant because it creates an internal referral pipeline: children diagnosed at an Already Autism Health location can begin ABA therapy at the same organization, reducing the time between diagnosis and treatment initiation.

As of early 2026, Already Autism Health serves individuals with autism spectrum disorder across seven states: North Carolina, South Carolina, Georgia, Kentucky, Indiana, Virginia, and Illinois. The company has approximately 450 employees, according to PitchBook data. The geographic footprint concentrates in the Southeast and Midwest — regions where demand for ABA services is growing rapidly, Medicaid coverage is expanding, and the competitive landscape is less saturated than the Northeast or West Coast.

The Sellers and Their Stories

The two acquisitions tell different but complementary stories about the ABA M&A market. Commonwealth ABA was a classic fast-build-and-sell: Brett Blevins founded the company in 2023, grew it to 15 locations across four states, and sold it to Already Autism Health within approximately 18 months. Blevins assumed the role of Chief Development Officer at Already Autism Health, then transitioned to Chief Administrative Officer. BHB reported that Blevins stayed on for approximately a year to integrate Commonwealth, Already, and C.A.B.S., then departed at the end of 2025 to launch a consultancy called Behavioral Wealth and Finance focused on helping BCBAs with personal finance.

Blevins’ rapid build-and-sell cycle is representative of the founder-to-exit pipeline that characterizes lower middle-market ABA M&A. BHB named Blevins one of the seven autism therapy industry executives to watch in 2026, noting his remarkably impactful career and his ability to build and sell companies in the behavioral health space. His departure from Already Autism Health and pivot to consulting suggests a serial entrepreneur who has moved through the cycle and is now advising others on how to replicate it.

C.A.B.S. Autism & Behaviour Specialists represents a different archetype: a BCBA-founded practice that operated for nearly two decades before selling. Amanda Parker founded C.A.B.S. in 2008 and built a reputation for evidence-based care in Illinois and Georgia. The sale to Already Autism Health provides the clinical credibility and operational maturity that a fast-growing platform needs to complement its organic growth with proven clinical programs. Parker’s 17-year tenure gives the combined organization a clinical heritage that a five-year-old platform cannot build from scratch.

Together, the acquisitions demonstrate the two primary supply channels for ABA platform M&A: recently founded, fast-growing practices built specifically for sale (Commonwealth), and established, clinician-founded practices that have reached a natural transition point (C.A.B.S.). Both types are abundant in the current market, and platforms like Already Autism Health that can acquire and integrate both types have a broader deal pipeline than those focused on only one.

Triton Pacific and the PE Thesis

Triton Pacific Healthcare Partners is the majority shareholder in Already Autism Health. The firm led the investment round with Star Mountain Capital and Ace & Company participating via debt and equity. Joe Davis, managing partner at Triton Pacific, described the strategic rationale in terms that reflect the broader PE thesis in ABA: the autism services space is undergoing rapid evolution but remains one of the most underserved sectors in all of healthcare.

Triton Pacific’s investment thesis rests on several structural tailwinds. Autism diagnosis rates continue to rise — the CDC’s 2025 report found that 1 in 31 children is now diagnosed with ASD, up from 1 in 36 previously and 1 in 150 in 2000. The demand for ABA services continues to outstrip supply, creating long waitlists in most markets. Insurance coverage mandates have expanded access, and Medicaid coverage is now universal across states. The workforce of BCBAs and RBTs continues to grow but not fast enough to meet demand.

The PE model in ABA follows a well-established playbook: acquire a founder-led platform with clinical credibility, add tuck-in acquisitions to build geographic density and scale, invest in operational infrastructure (EHR, billing, compliance, HR), and position the platform for eventual exit to a larger sponsor or strategic acquirer at a higher valuation multiple. Triton Pacific’s decision to invest in Already Autism Health — rather than in a larger, more established platform — suggests the firm sees value in the early-stage growth opportunity, where the multiple expansion from a small base can generate higher returns than investing in a mature platform at peak valuations.

The investment also reflects a market reality: after the 2022–2024 correction in ABA valuations, driven by wage inflation, rate pressure, and high-profile provider bankruptcies, the entry point for new PE investors has become more favorable. Kevin Taggart of Mertz Taggart noted that during COVID and right after, ABA companies experienced wage inflation without getting rate increases, leading to high-profile bankruptcies. The dust has settled, and now we’re seeing a lot of groups asking for ABA businesses. Triton Pacific’s January 2025 investment was made at a time when valuations had corrected from their 2021 peaks but demand fundamentals remained strong.

The Early-2025 Dealmaking Context

Already Autism Health’s three deals were not isolated. They occurred within a broader surge of ABA M&A activity in early 2025. Mertz Taggart reported 12 I/DD and autism transactions in Q1 2025 — the highest quarterly volume since 2021. The Braff Group reported 14 deals, a 133 percent year-over-year increase. PricewaterhouseCoopers reported that behavioral health dealmaking was up 35 percent in Q1 2025, with autism therapy deals reaching the highest quarterly count since 2020.

Other notable transactions in the same period included Ascend Capital Partners acquiring a majority stake in Unison Therapy Services, Leavitt Equity Partners partnering with Pediatrics Plus in Arkansas, BrightSpring Health Services divesting its I/DD division to Sevita for $835 million, and Frontera Health raising $32 million in seed funding for an AI-powered autism services platform. The market was moving, and Already Autism Health was moving with it.

The competitive landscape for acquisitions was also intensifying. Taggart noted that one ABA company Mertz Taggart was working with in Q1 2025 received the highest number of offers for any deal the firm had worked on since 2021. The buyer appetite had returned, driven by PE firms with undeployed capital, strategic acquirers seeking geographic expansion, and the fundamental supply-demand imbalance in ABA services that makes the sector attractive despite the regulatory headwinds.

What Comes Next

For Already Autism Health, the next phase of the platform build will determine whether the three-deal January 2025 strategy produces the returns that Triton Pacific is targeting. The company needs to integrate two acquisitions with different cultures, systems, and clinical practices while simultaneously pursuing organic growth through new center openings and service line additions. Integration is the hardest part of the PE-backed roll-up model, and many ABA platforms have stumbled at this stage.

The addition of diagnostic evaluation services represents a differentiation strategy that could set Already Autism Health apart from competitors. The autism diagnosis bottleneck — long waitlists for developmental pediatricians and psychologists who can evaluate children for ASD — is one of the most significant access barriers in the field. A provider that can offer both diagnosis and treatment under one roof addresses the bottleneck directly and creates a patient pipeline that competitors without diagnostic services cannot replicate.

The regulatory environment will also shape the company’s trajectory. Already Autism Health operates in Indiana, where FSSA Secretary Mitch Roob imposed a 4,000-hour lifetime cap and self-reporting ultimatum in early 2026. The company operates in states where OIG audits have been completed (Indiana) and states where audits may be forthcoming. The compliance infrastructure that Triton Pacific funds — or fails to fund — will determine whether Already Autism Health navigates the enforcement environment successfully or becomes another case study in PE-backed growth outpacing compliance.

For the ABA industry, Already Autism Health represents the emerging model of early-stage PE-backed platform building: a founder-led company with demonstrated organic growth, clinical accreditation, and a geographic footprint that can be expanded through coordinated tuck-in acquisitions. The model is being replicated across the country by dozens of PE firms and hundreds of acquisition targets. Whether it produces sustainable clinical quality alongside financial returns — or whether it produces the next wave of audit findings and enforcement actions — is the question that will define this generation of ABA platforms.

AT A GLANCE

SOURCES & REFERENCES